These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7456636)

  • 1. [Coagulation properties of the extravascular fluid. II. Components of the fibrinolytic system in thoracic-duct lymph].
    Müller N; Danckworth HP
    Z Lymphol; 1980 Jul; 4(1):18-20. PubMed ID: 7456636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coagulation and fibrinolytic properties of the lymph from the thoracic duct of dogs].
    Pukhov VV
    Zdravookhr Kirg; 1980; (1):31-4. PubMed ID: 6103610
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coagulation properties of the extravascular fluid. I. Coagulation factors in thoracic-duct lymph].
    Müller N; Danckworth HP
    Z Lymphol; 1980 Jul; 4(1):11-7. PubMed ID: 7456635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic activity in dogs after surgically induced trauma.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1137-40. PubMed ID: 8836363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factors and components of the fibrinolytic system in lymph and blood in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Thromb Diath Haemorrh; 1968 Mar; 19(1):129-35. PubMed ID: 5652223
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the heart in the mechanism modifying the functional state of the blood clotting and fibrinolytic systems in thyroxine toxicosis.
    Georgieva SA; Kirichuk VF
    Cor Vasa; 1981; 23(4):310-5. PubMed ID: 7297076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
    Schultze AE; Roth RA
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):129-37. PubMed ID: 7687795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma antiplasmin activities in experimental lung insufficiency.
    Aasen AO; Saugstad OD; Lium B; Guldvog I; Lyngaas K; Larsbraaten M; Amundsen E
    Acta Chir Scand Suppl; 1980; 499():113-21. PubMed ID: 6935891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [State of the fibrinolytic and kinin systems of the blood after physical loading].
    Andreenko GV; Liutova LV; Beniumova OE
    Fiziol Zh SSSR Im I M Sechenova; 1980 Oct; 66(10):1473-80. PubMed ID: 7192224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic abnormalities following liver transplantation in patients with fulminant hepatic failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):155-9. PubMed ID: 7536112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the fibrinolytic system in myocardial infarction].
    Moreno JA; Cornudella R; Gálvez M; Angós JA; Romero S; Gutiérrez M
    Sangre (Barc); 1994 Feb; 39(1):23-7. PubMed ID: 8197514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic abnormalities of the fibrinolytic system.
    Aoki N
    Prog Clin Biol Res; 1981; 72():229-47. PubMed ID: 7199719
    [No Abstract]   [Full Text] [Related]  

  • 19. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
    Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
    Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.